ProfileGDS4718 / 221964_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 68% 70% 76% 70% 68% 76% 75% 69% 68% 70% 69% 69% 75% 74% 77% 72% 69% 74% 76% 83% 71% 69% 67% 67% 71% 74% 67% 78% 71% 76% 71% 76% 73% 69% 84% 76% 77% 69% 70% 77% 69% 73% 76% 79% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.7306668
GSM549102patient 115, normal, homogenized [OPG study]6.8324670
GSM549104patient 119, normal, homogenized [OPG study]7.4977176
GSM549108patient 138, normal, homogenized [OPG study]6.8560670
GSM549119patient 077, normal, homogenized [OPG study]6.6730868
GSM549133patient 032, cancer, homogenized [OPG study]7.5700976
GSM549139patient 042, cancer, homogenized [OPG study]7.3885275
GSM549099patient 107, normal, homogenized [OPG study]6.7294669
GSM549109patient 139, normal, homogenized [OPG study]6.6682168
GSM549110patient 046, normal, homogenized [OPG study]6.8758770
GSM549114patient 063, normal, homogenized [OPG study]6.7998269
GSM549122patient 082, normal, homogenized [OPG study]6.7916369
GSM549134patient 033, cancer, homogenized [OPG study]7.3805475
GSM549136patient 036, cancer, homogenized [OPG study]7.3398474
GSM549140patient 044, cancer, homogenized [OPG study]7.6469477
GSM549111patient 047, normal, homogenized [OPG study]7.0661372
GSM549113patient 057, normal, homogenized [OPG study]6.8217769
GSM549132patient 031, cancer, homogenized [OPG study]7.2923174
GSM549137patient 038, cancer, homogenized [OPG study]7.4337976
GSM549142patient 047, cancer, homogenized [OPG study]7.9009183
GSM549100patient 110, normal, homogenized [OPG study]6.8697171
GSM549107patient 135, normal, homogenized [OPG study]6.8101969
GSM549115patient 068, normal, homogenized [OPG study]6.6639267
GSM549116patient 072, normal, homogenized [OPG study]6.6105967
GSM549120patient 078, normal, homogenized [OPG study]6.943771
GSM549131patient 030, cancer, homogenized [OPG study]7.3756274
GSM549118patient 074, normal, homogenized [OPG study]6.6139167
GSM549129patient 027, cancer, homogenized [OPG study]7.6861178
GSM549123patient 088, normal, homogenized [OPG study]6.9943271
GSM549124patient 006, cancer, homogenized [OPG study]7.3402976
GSM549126patient 015, cancer, homogenized [OPG study]6.981971
GSM549128patient 025, cancer, homogenized [OPG study]7.5681476
GSM549103patient 117, normal, homogenized [OPG study]7.0918273
GSM549117patient 073, normal, homogenized [OPG study]6.6970269
GSM549138patient 041, cancer, homogenized [OPG study]8.3412984
GSM549141patient 045, cancer, homogenized [OPG study]7.5012876
GSM549130patient 028, cancer, homogenized [OPG study]7.4942977
GSM549101patient 111, normal, homogenized [OPG study]6.8031769
GSM549105patient 128, normal, homogenized [OPG study]6.8328770
GSM549106patient 134, normal, homogenized [OPG study]7.7094577
GSM549112patient 048, normal, homogenized [OPG study]6.7841669
GSM549125patient 011, cancer, homogenized [OPG study]7.1235173
GSM549127patient 024, cancer, homogenized [OPG study]7.480976
GSM549135patient 035, cancer, homogenized [OPG study]7.8659879